This collaboration brings together The Global Health Network AMR Knowledge Hub and the Global Antimicrobial Stewardship Partnership Hub (GASPH). The AMR Knowledge Hub is a free resource and global community of practice (CoP), open to all researchers, healthcare and laboratory teams in all organisations working in AMR research. GASPH is an open-access, global, AMR learning platform founded and run by BSAC for the global AMR community. Through supporting AMR research and stewardship globally both hubs are committed to tackling one of the biggest healthcare – and humanitarian – challenges we collectively face.
The aim is to incrementally grow the resources and activities of the two AMR hubs with their respective partners and collaborators, moving towards the vision articulated by Wernli D et al (Lancet ID 2020) of creating a unified, multi-stakeholder, open-access, global learning platform and community of practice for AMR.
BSAC is a professional society and global educator, connecting scientific researchers, medical communities and the wider public to stop the growing threat of drug-resistant infections.
The Global Health Network is a vast and trusted open knowledge community transferring know-how across disease areas, types of research and between organisations, networks and regions. The vision is to build equity in where health research happens, who leads and who benefits. The Global Health Network is a WHO collaborating centre for research information sharing, e-learning, and capacity development.
“As one of the world’s leading infectious disease societies, we are delighted to collaborate with The Global Health Network” said Tracey Guise, BSAC Chief Executive Officer. “This MoU signals the enhancement of a partnership that will allow us to maximize the impact of our complementary activities and increase the global reach of our respective open-access global health learning platforms.”
Professor Trudie Lang, Director of The Global Health Network at the University of Oxford said: “There remains vast disparity across the globe regarding AMR research and who benefits from the evidence and new interventions. There is a vital need to improve access to high quality, open-access learning resources, designed to meet the needs of the AMR research community in settings where they are needed most. This exciting collaboration with BSAC to amplify our collective efforts in addressing AMR across the world can help us get there.”
About The Global Health Network
The Global Health Network is a vast and highly-connected community of health workers and health research organisations, that enables research in every healthcare setting by driving equity in where research happens, who leads and who benefits from the evidence. This works by mobilising knowledge between organisations, across disease areas and different geographies.
Embedded within many countries across the world, this community runs research system-strengthening programmes to integrate research within healthcare practice by facilitating workplace-based learning, local research support activities, and professional development for research teams.
The Global Health Network’s digital platform hosts diverse knowledge hubs, each led by different organisations and networks. These hubs serve as dynamic catalysts, broadening engagement, uptake and impact across a spectrum of health research disciplines, topics, and disease areas. Within this dynamic ecosystem are a multitude of open-access health research resources including tools, guidelines, templates, methodologies, training courses, databases, webinars and workshops.
Together these approaches are connecting networks, linking research groups and sharing excellence, consequently increasing research progress, raising standards and ensuring efficiency.
The Global Health Network is a WHO collaborating centre because of this effort to enable teams everywhere in the world to undertake and lead research studies that address local priority health challenges.
The British Society for Antimicrobial Chemotherapy (BSAC) is an inter-professional organisation and global educator, with members in 135 countries around the world. Founded in 1971, the Society has half a century of experience and achievement in antibiotic education, research, and leadership. Dedicated to saving lives through the appropriate development and use of antibiotics, it supports a large global network via events, online education, professional guidelines and its own international journals, the Journal of Antimicrobial Chemotherapy (JAC) and its sister publication, JAC-AMR. www.bsac.org.uk